Luisa Carbognin
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study.
Journal: Breast (Edinburgh, Scotland)
Published: February 22, 2026
Temporal patterns and factors associated with early termination in phase 1 clinical trials for solid tumors.
Journal: Journal of the National Cancer Institute
Published: December 22, 2025
Personalizing Adjuvant Endocrine Therapy for Breast Cancer.
Journal: JAMA network open
Published: November 03, 2025
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 11, 2025
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study.
Journal: Future oncology (London, England)
Published: June 14, 2025
HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations.
Journal: International journal of molecular sciences
Published: May 23, 2025
Digital integration of narrative medicine and patient-reported outcome measures to improve understanding of quality of life in metastatic breast cancer: the PERGIQUAL study.
Journal: The oncologist
Published: May 08, 2025
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer.
Journal: JNCI cancer spectrum
Published: April 10, 2025
Cognitive effects of aromatase inhibitors in early breast cancer patients: a prospective study.
Journal: Breast cancer research and treatment
Published: April 07, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study.
Journal: Clinical breast cancer
Published: November 23, 2024
Role of radiomics in predicting early disease recurrence in locally advanced breast cancer patients: integration of radiomic features and RECIST criteria.
Journal: La Radiologia medica
Published: September 13, 2024
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan.
Journal: NPJ precision oncology
Published: April 30, 2024
Last Updated: 09/26/2026